BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32001615)

  • 1. Homozygous Hypomorphic
    Misra S; Hassanali N; Bennett AJ; Juszczak A; Caswell R; Colclough K; Valabhji J; Ellard S; Oliver NS; Gloyn AL
    Diabetes Care; 2020 Apr; 43(4):909-912. PubMed ID: 32001615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort.
    Bacon S; Kyithar MP; Rizvi SR; Donnelly E; McCarthy A; Burke M; Colclough K; Ellard S; Byrne MM
    Diabet Med; 2016 Jul; 33(7):976-84. PubMed ID: 26479152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mexican Carriers of the
    Martagón AJ; Bello-Chavolla OY; Arellano-Campos O; Almeda-Valdés P; Walford GA; Cruz-Bautista I; Gómez-Velasco DV; Mehta R; Muñoz-Hernández L; Sevilla-González M; Viveros-Ruiz TL; Ordoñez-Sánchez ML; Rodríguez-Guillen R; Florez JC; Tusié-Luna MT; Aguilar-Salinas CA;
    Diabetes Care; 2018 Aug; 41(8):1726-1731. PubMed ID: 29844095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment.
    Schnedl WJ; Holasek SJ; Schenk M; Enko D; Mangge H
    Wien Klin Wochenschr; 2021 Mar; 133(5-6):241-244. PubMed ID: 33245425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HNF1A mutant Ala180Val: Clinical challenges in determining causality of a rare HNF1A variant in familial diabetes.
    Sagen JV; Bjørkhaug L; Haukanes BI; Grevle L; Molnes J; Nedrebø BG; Søvik O; Njølstad PR; Johansson S; Molven A
    Diabetes Res Clin Pract; 2017 Nov; 133():142-149. PubMed ID: 28934671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New clinical screening strategy to distinguish
    Ma Y; Gong S; Wang X; Cai X; Xiao X; Gu W; Yang J; Zhong L; Xiao J; Li M; Liu W; Zhang S; Zhou X; Li Y; Zhou L; Zhu Y; Luo Y; Ren Q; Huang X; Gao X; Zhang X; Zhang R; Chen L; Wang F; Wang Q; Hu M; Han X; Ji L
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32238361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Fucosylated Glycans and C-Reactive Protein as Biomarkers of HNF1A-MODY in Young Adult-Onset Nonautoimmune Diabetes.
    Juszczak A; Pavić T; Vučković F; Bennett AJ; Shah N; Pape Medvidović E; Groves CJ; Šekerija M; Chandler K; Burrows C; Rojnić Putarek N; Vučić Lovrenčić M; Ćuća Knežević J; James TJ; Gloyn AL; Lauc G; McCarthy MI; Owen KR; Gornik O
    Diabetes Care; 2019 Jan; 42(1):17-26. PubMed ID: 30455330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturity onset diabetes of the young: Seek and you will find.
    Heuvel-Borsboom H; de Valk HW; Losekoot M; Westerink J
    Neth J Med; 2016 Jun; 74(5):193-200. PubMed ID: 27323672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maturity onset diabetes of the young due to
    Pavić T; Juszczak A; Pape Medvidović E; Burrows C; Šekerija M; Bennett AJ; Ćuća Knežević J; Gloyn AL; Lauc G; McCarthy MI; Gornik O; Owen KR
    Biochem Med (Zagreb); 2018 Jun; 28(2):020703. PubMed ID: 29666556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MODY in Ukraine: genes, clinical phenotypes and treatment.
    Globa E; Zelinska N; Elblova L; Dusatkova P; Cinek O; Lebl J; Colclough K; Ellard S; Pruhova S
    J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1095-1103. PubMed ID: 28862987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digenic heterozygous HNF1A and HNF4A mutations in two siblings with childhood-onset diabetes.
    Shankar RK; Ellard S; Standiford D; Pihoker C; Gilliam LK; Hattersley A; Dolan LM
    Pediatr Diabetes; 2013 Nov; 14(7):535-8. PubMed ID: 23551881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
    Ellard S; Colclough K
    Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a(-/-) Model.
    Urbanova J; Andel M; Potockova J; Klima J; Macek J; Ptacek P; Mat'oska V; Kumstyrova T; Heneberg P
    Curr Pharm Des; 2015; 21(39):5736-48. PubMed ID: 26446475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsupervised Clustering of Missense Variants in HNF1A Using Multidimensional Functional Data Aids Clinical Interpretation.
    Althari S; Najmi LA; Bennett AJ; Aukrust I; Rundle JK; Colclough K; Molnes J; Kaci A; Nawaz S; van der Lugt T; Hassanali N; Mahajan A; Molven A; Ellard S; McCarthy MI; Bjørkhaug L; Njølstad PR; Gloyn AL
    Am J Hum Genet; 2020 Oct; 107(4):670-682. PubMed ID: 32910913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of young patients with HNF1A mutations (HNF1A-MODY).
    Raile K; Schober E; Konrad K; Thon A; Grulich-Henn J; Meissner T; Wölfle J; Scheuing N; Holl RW;
    Diabet Med; 2015 Apr; 32(4):526-30. PubMed ID: 25483937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alternative approach using hs-CRP levels and age of onset in diagnostics of HNF1A-MODY.
    Kickova T; Skopkova M; Dobiasova Z; Lackova G; Belicova Z; Schenkova K; Stanik J; Gasperikova D
    Diabet Med; 2024 May; 41(5):e15265. PubMed ID: 38093550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.
    Owen KR; Thanabalasingham G; James TJ; Karpe F; Farmer AJ; McCarthy MI; Gloyn AL
    Diabetes Care; 2010 Sep; 33(9):1919-24. PubMed ID: 20724646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous ABCC8 mutations are a cause of MODY.
    Bowman P; Flanagan SE; Edghill EL; Damhuis A; Shepherd MH; Paisey R; Hattersley AT; Ellard S
    Diabetologia; 2012 Jan; 55(1):123-7. PubMed ID: 21989597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful switch from insulin to oral sulfonylurea therapy in HNF1A-MODY Tunisian patient with the P291fsinsC mutation.
    Khelifa SB; Dendana A; Barboura I; Khochtali I; Chahed H; Ferchichi S; Miled A
    Diabetes Res Clin Pract; 2016 May; 115():133-6. PubMed ID: 26822262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
    McDonald TJ; Shields BM; Lawry J; Owen KR; Gloyn AL; Ellard S; Hattersley AT
    Diabetes Care; 2011 Aug; 34(8):1860-2. PubMed ID: 21700917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.